They already are taking the first step in mass production, making 10,000 doses funded by a foundation and the U.K. government (http://www.theguardian.com/societ

They already are taking the first step in mass production, making 10,000 doses funded by a foundation and the U.K. government (http://www.theguardian.com/society/2014/sep/17/ruth-atkins-first-british-volunteer-injected-trial-ebola-vaccine-oxford http://www.theguardian.com/society/2014/sep/17/ruth-atkins-f...). When you do this sort of thing there's generally an intermediate step between producing a small number of doses in "the lab" and real mass production, where you figure out how to efficiently and safely produce mass quantities.